PREDICTORS OF SERIOUS INFECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TARGET THERAPY.

被引：0
|
作者：
Koltsova, E. [1 ,2 ]
Lukina, G. [2 ,3 ]
Shmidt, E. [4 ]
Lytkina, K. [5 ]
Zhilyaev, E. [6 ,7 ]
机构：
[1] Org Hlth & Healthcare Management, Res Inst, Moscow, Russia
[2] AS Loginov Moscow Clin Sci Ctr, Moscow, Russia
[3] VA Nasonova Res Inst Rheumatol, Moscow, Russia
[4] NI Pirogov City Clin Hosp, Moscow, Russia
[5] City Clin Hosp, Moscow, Russia
[6] European Med Ctr, Moscow, Russia
[7] Minist Healthcare Russian Federat, Russian Med Acad Continuous Profess Educ, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.6227
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0303
引用
收藏
页码：1447 / 1447
页数：1
相关论文
共 50 条
  • [41] Rates and predictors of joint and bone infections in patients with rheumatoid arthritis.
    Wolfe, F
    Michaud, K
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S477 - S478
  • [42] Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis
    Costenbader, Karen H.
    Glass, Roberta
    Cui, Jing
    Shadick, Nancy
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (18): : 2201 - 2201
  • [43] Repeated Rituximab Infusions for the Therapy of Rheumatoid Arthritis Is Not Associated with Increased Rates of Serious Infections
    Pappas, Dimitrios A.
    Reed, George W.
    Zlotnick, Steve
    Best, Jennie
    Magner, Robert
    Persuitte, Gioia
    Greenberg, Jeffrey D.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [44] Intracellular cytokine profiles in T-lymphocytes and monocytes of rheumatoid arthritis patients, receiving anti-TNF-α therapy.
    Schuerwegh, AJ
    Bridts, CH
    Stevens, WJ
    De Clerck, LS
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S297 - S297
  • [45] Incidence and predictors of serious bleeding following polypectomy in patients receiving and not receiving oral anticoagulation therapy
    Witt, D. M.
    Delate, T.
    McCool, K. H.
    Dowd, M.
    Clark, N. P.
    Crowther, M. A.
    Garcia, D. A.
    Ageno, W.
    Dentali, F.
    Hylek, E. M.
    Rector, W. G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 475 - 475
  • [46] Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment
    Holten, Karen
    Sundlisater, Nina Paulshus
    Lillegraven, Siri
    Sexton, Joseph
    Nordberg, Lena Bugge
    Moholt, Ellen
    Hammer, Hilde Berner
    Uhlig, Till
    Kvien, Tore K.
    Haavardsholm, Espen A.
    Aga, Anna-Birgitte
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (03) : 344 - 350
  • [47] The treatment of rheumatoid arthritis: Current trends in therapy.
    Mikuls, T
    O'Dell, J
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S79 - S79
  • [48] Immunological predictors of fatigue outcomes in prostate cancer patients receiving radiation therapy.
    Feng, Li Rebekah
    Wolff, Brian S.
    Lukkahatai, Nada
    Saligan, Leorey N.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [49] DRUG SURVIVAL AND THE ASSOCIATED PREDICTORS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TACROLIMUS
    Park, E. K.
    Lee, S. G.
    Koo, D. W.
    Kim, G. T.
    Lee, J. W.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 978 - 979
  • [50] PREDICTORS OF DRUG SURVIVAL OF BDMARDS IN BIO-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS (RA) DURING THE FIRST YEAR OF THERAPY.
    Aronova, E.
    Lukina, G.
    Gridneva, G.
    Glukhova, S.
    Kudryavtseva, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1431 - 1431
12345